Lasezkay M. George's most recent trade in Clearside Biomedical Inc was a trade of 439,500 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clearside Biomedical Inc | Lasezkay M. George | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 439,500 | 439,500 | - | - | Employee Stock Option (right to buy) | |
| Clearside Biomedical Inc | Lasezkay M. George | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 18 Jan 2024 | 18,000 | 466,577 (1%) | 0% | 1.3 | 22,860 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 487,500 | 487,500 | - | - | Employee Stock Option (right to buy) | |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 292,500 | 292,500 | - | - | Stock Option (Right to Buy) | |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 97,500 | 515,407 (1%) | 0% | 0 | Common Stock | |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.12 per share. | 18 Jan 2022 | 10,800 | 504,607 (1%) | 0% | 2.1 | 22,896 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 11 Jan 2022 | 5,100 | 417,907 (0%) | 0% | 2.5 | 12,546 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 6.46 per share. | 21 Sep 2021 | 3,525 | 423,007 (0%) | 0% | 6.5 | 22,772 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 21 Jun 2021 | 3,707 | 426,532 (0%) | 0% | 4.4 | 16,237 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 19 Mar 2021 | 3,370 | 430,239 (0%) | 0% | 2.8 | 9,503 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.37 per share. | 02 Mar 2021 | 6,000 | 433,609 (0%) | 0% | 3.4 | 20,220 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 284,750 | 284,750 | - | - | Stock Option (Right to Buy) | |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 140,250 | 439,609 (0%) | 0% | 0 | Common Stock | |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 21 Dec 2020 | 3,330 | 299,359 (0%) | 0% | 2.1 | 6,893 | Common Stock |
| Clearside Biomedical Inc | George M. Lasezkay | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 22 Sep 2020 | 13,411 | 302,689 (0%) | 0% | 1.6 | 21,323 | Common Stock |